🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Inflammatory synaptopathy is a prominent pathogenic process in multiple scl...
Status
Unknown
Location
IRCCS INM-Neuromed
Start Date
2023-07-26
Trial ID
NCT05779449
This study will evaluate the efficacy and safety of ocrelizumab (Ocrevus®) ...
Status
Active Not Recruiting
Location
Georgetown University Medical Center
Start Date
2019-08-12
Trial ID
NCT04035005
Treatments Being Tested
This study is a prospective, multi-center, randomized, double blinded, plac...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2023-02-07
Trial ID
NCT05285891
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, Phase ...
Status
Terminated
Location
Yale University
Start Date
2022-02-15
Trial ID
NCT04877457
Treatments Being Tested
This randomized, parallel group, double-blind, placebo controlled study wil...
Status
Completed
Location
Phoenix Neurological Associates Ltd
Start Date
2011-03-02
Trial ID
NCT01194570
Treatments Being Tested
This randomized, double-blind, double-dummy, parallel-group study will eval...
Status
Completed
Location
21st Century Neurology
Start Date
2011-08-31
Trial ID
NCT01247324
Treatments Being Tested
This randomized, double-blind, double-dummy, parallel-group study will eval...
Status
Completed
Location
Hope Research Institute
Start Date
2011-09-20
Trial ID
NCT01412333
Treatments Being Tested
As the in vivo reservoir of the Epstein-Barr virus, B cells play an importa...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2022-09-15
Trial ID
NCT04880577
Treatments Being Tested
Some people who have what doctors currently call schizophrenia or bipolar d...
Status
Recruiting
Location
Houston Methodist Research Institute
Start Date
2019-10-01
Trial ID
NCT03971487
This is a Phase III, randomized, double-blind, placebo-controlled, multicen...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02-15
Trial ID
NCT00626197
Treatments Being Tested